H.C. Wainwright Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Cuts Target Price to $2

Futu NewsMar 25 14:32

BTIG Maintains Buy on Ovid Therapeutics, Lowers Price Target to $4

BenzingaMar 24 21:29

Ovid Therapeutics: Strategic Pipeline Reprioritization and Promising KCC2 Portfolio Drive Buy Rating

TipRanksMar 24 18:19

Ovid Therapeutics Analyst Ratings

BenzingaMar 12 22:28

William Blair Initiates Ovid Therapeutics(OVID.US) With Buy Rating

Futu NewsMar 12 19:32

Wedbush Adjusts Price Target on Ovid Therapeutics to $3 From $4, Keeps Outperform Rating

MT NewswiresMar 12 18:26

William Blair Sticks to Their Buy Rating for Ovid Therapeutics (OVID)

TipRanksMar 12 16:22

Oppenheimer Upgrades Ovid Therapeutics(OVID.US) to Buy Rating, Announces Target Price $4

Futu NewsJan 30 14:32

Oppenheimer Upgrades Ovid Therapeutics to Outperform From Perform, $4 Price Target

MT NewswiresJan 29 23:30

BTIG Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $5

Futu NewsDec 10, 2024 20:36

Ovid Therapeutics' OV329: Promising Safety and Efficacy Lead to Buy Rating

TipRanksDec 10, 2024 20:07

Wedbush Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $4

Futu NewsDec 9, 2024 21:31

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM) and Ovid Therapeutics (OVID)

TipRanksDec 9, 2024 21:24

H.C. Wainwright Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $3

Futu NewsDec 6, 2024 00:36

Ovid Therapeutics Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow JonesDec 4, 2024 19:59

Ovid Therapeutics Analyst Ratings

BenzingaDec 4, 2024 19:49

Wedbush Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 14, 2024 22:33

TD Cowen Maintains Ovid Therapeutics(OVID.US) With Buy Rating

Futu NewsNov 14, 2024 21:31

Oppenheimer Maintains Ovid Therapeutics(OVID.US) With Hold Rating

Futu NewsNov 14, 2024 21:31

BTIG Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $5

Futu NewsNov 14, 2024 20:32